Circulating adiponectin levels are reduced in obese individuals, and it was proposed to have a crucial role in the pathogenesis of atherosclerosis and cardiovascular diseases associated with obesity and metabolic syndrome. Here, ADIPOQ is linked to atherosclerosis.